Bayer to Present New Clinical Data in Indolent non-Hodgkin’s Lymphoma and Additional Research …,

Oral presentation in Clinical Trials Plenary Session on April 10 to highlight the Phase III trial CHRONOS-3 evaluating the investigational combination …, Oral presentation in Clinical Trials Plenary Session on April 10 to highlight the Phase III trial CHRONOS-3 evaluating the investigational combination …, Read More

Scroll to Top